Cargando…
Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?
SIMPLE SUMMARY: Glioblastoma multiforme (GBM) is the most common type of malignant brain tumor. GBM patients face a dire future, as they rarely survive longer than 15 months after diagnosis. Typically, patients undergo surgery to remove the tumor followed by combined radiotherapy and chemotherapy. H...
Autores principales: | Aldaz, Paula, Arozarena, Imanol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616487/ https://www.ncbi.nlm.nih.gov/pubmed/34830952 http://dx.doi.org/10.3390/cancers13225799 |
Ejemplares similares
-
Novel Insights into the Role of the Mineralocorticoid Receptor in Human Glioblastoma
por: Aldaz, Paula, et al.
Publicado: (2021) -
Microphthalmia‐associated transcription factor in melanoma development and MAP‐kinase pathway targeted therapy
por: Wellbrock, Claudia, et al.
Publicado: (2015) -
The Complexity of the ERK/MAP-Kinase Pathway and the Treatment of Melanoma Skin Cancer
por: Wellbrock, Claudia, et al.
Publicado: (2016) -
Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
por: Brar, Harpinder K., et al.
Publicado: (2022) -
Closing a chapter
por: Westgarth, David
Publicado: (2022)